Hikma Pharmaceuticals buy BNP Paribas
Start price
14.05.25
/
50%
€23.40
Target price
14.05.26
-
Performance (%)
-31.77%
Price
08:01
?
Summary
This prediction is currently active. The BUY prediction by BNP_Paribas for Hikma Pharmaceuticals is performing very badly with a performance of -31.77%. A total of €0.41 was paid as dividends for this prediction. This prediction currently runs until 14.05.26. The prediction end date can be changed by BNP_Paribas at any time. BNP_Paribas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | 4.937% | 4.937% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by BNP_Paribas for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals PLC (OTCMKTS: HKMPF) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.
Ratings data for HKMPF provided by MarketBeat